Similarly, there were gender differences in ESPL1 expression levels, with higher expression levels observed in females in KIRP, LIHC, and SARC, and males had higher expression levels in LAML and LUAD (Supplementary Figure 3B).3.2 ESPL1 has potential as a tumor prognostic marker. This evidence concerns the gene ESPL1 and neoplasm.